X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12) 12
animals (5) 5
hematology (5) 5
humans (5) 5
mice (4) 4
oncology (4) 4
blinatumomab (3) 3
bone marrow (3) 3
bone marrow - pathology (3) 3
cell biology (3) 3
food and beverages (3) 3
male (3) 3
megakaryocyte (3) 3
megakaryocytes - enzymology (3) 3
minimal residual disease (3) 3
phase-ii (3) 3
polyploidy (3) 3
protein-lysine 6-oxidase - metabolism (3) 3
treatment outcome (3) 3
abridged index medicus (2) 2
acute lymphoblastic leukemia (2) 2
acute lymphocytic-leukemia (2) 2
adult (2) 2
adult patients (2) 2
aged (2) 2
biochemistry & molecular biology (2) 2
blotting, western (2) 2
bone marrow - metabolism (2) 2
cancer (2) 2
case report (2) 2
chemotherapy (2) 2
diseases of the blood and blood-forming organs (2) 2
endomitotic cell-cycle (2) 2
enzymes and coenzymes (2) 2
essential thrombocythemia (2) 2
female (2) 2
flow cytometry (2) 2
fluorescent antibody technique (2) 2
growth-factor (2) 2
hematopoiesis (2) 2
in-vivo (2) 2
integumentary system (2) 2
leukemia (2) 2
megakaryocytes - cytology (2) 2
mice, transgenic (2) 2
middle aged (2) 2
monoclonal-antibody (2) 2
myeloproliferative neoplasms (2) 2
platelet (2) 2
platelet production (2) 2
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (2) 2
primary myelofibrosis - pathology (2) 2
relapse (2) 2
residual disease (2) 2
retrospective studies (2) 2
single-chain antibody (2) 2
transplantation (2) 2
urogenital system (2) 2
1st relapse (1) 1
60 applied life sciences (1) 1
accumulation (1) 1
activated-protein-kinase (1) 1
activation (1) 1
acute leukemia (1) 1
acute lymphoblastic-leukemia (1) 1
acute lymphocytic leukemia (1) 1
acute megakaryoblastic leukemia (1) 1
acute myeloid leukemia (1) 1
acute promyelocytic leukemia (1) 1
adolescent (1) 1
antibodies, bispecific - chemistry (1) 1
antibodies, bispecific - pharmacology (1) 1
antibodies, bispecific - therapeutic use (1) 1
antineoplastic agents - chemistry (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
ara-c (1) 1
article subject (1) 1
ato (1) 1
atra (1) 1
b-cell precursor (1) 1
b-lineage (1) 1
beta-aminopropionitrile (1) 1
biodegradation, environmental (1) 1
biological recovery (1) 1
biopsy (1) 1
bispecific antibody (1) 1
blood platelets - cytology (1) 1
blood platelets - drug effects (1) 1
blood platelets - metabolism (1) 1
bone marrow - enzymology (1) 1
bone-marrow fibrosis (1) 1
breast-cancer (1) 1
breast-cancer cells (1) 1
c-myc (1) 1
cadmium (1) 1
cadmium - analysis (1) 1
cadmium - pharmacokinetics (1) 1
carotid artery injuries - complications (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Acta Haematologica, ISSN 0001-5792, 11/2019, pp. 1 - 2
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5192 - 5192
Abstract Introduction: The role of maintenance treatment in patients with high-risk Acute Promyelocytic Leukemia (APL) in the era of ATO/ATRA is unclear.... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2687 - 2687
Abstract Introduction: The optimum number of cycles and dose of Cytarabine consolidation in older patients (age 60 and above) with AML in first remission... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5120 - 5120
Introduction: The advent of Tyrosine Kinase Inhibitors (TKI) changed the treatment paradigm of Philadelphia chromosome Positive (Ph+) Acute Lymphoblastic... 
Journal Article
Future Oncology, ISSN 1479-6694, 06/2015, Volume 11, Issue 12, pp. 1729 - 1739
The treatment of acute lymphoblastic leukemia (ALL) in adults remains challenging and novel therapies are needed. The antigen, CD19, is expressed by >90% of... 
bispecific antibody | blinatumomab | minimal residual disease | acute lymphoblastic leukemia | relapse | ACUTE LYMPHOCYTIC-LEUKEMIA | SINGLE-CHAIN ANTIBODY | PHASE-II | MONOCLONAL-ANTIBODY | CYTOTOXIC T-LYMPHOCYTES | CELL-ENGAGING ANTIBODY | B-LINEAGE | LYMPHOMA-CELLS | ONCOLOGY | TERM-FOLLOW-UP
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2688 - 2688
Abstract Introduction: The initial response to standard induction chemotherapy for acute myeloid leukemia (AML) is commonly assessed with day 14 bone marrow... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2601 - 2601
Background: Overexpression of CD123, the alpha subunit of the IL-3 receptor, is characteristic of a number of hematological malignancies, including acute... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2656 - 2656
Background Protein arginine methyltransferase 5 (PRMT5) is the primary enzyme responsible for symmetric arginine dimethylation of multiple proteins that impact... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 4999 - 4999
Abstract BACKGROUND: Glioblastoma (GBM) is most common primary malignant brain tumor, and has a median survival of 15-18 months. Dovitinib, an oral... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 27 - 27
Abstract INTRODUCTION: Overexpression of CD123, the alpha subunit of the IL-3 receptor, in multiple hematological malignancies, including acute myeloid... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 26 - 26
Abstract INTRODUCTION: The myeloid differentiation antigen CD33 is an established therapeutic target in acute myeloid leukemia (AML). In addition to its broad... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 5006 - 5006
Abstract Background: The role of post treatment imaging in classical Hodgkin's Lymphoma (cHL) is an area of active investigation. There is significant interest... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1334 - 1334
Background: Overexpression of CD123, the alpha subunit of the IL-3 receptor, occurs in multiple hematological malignancies, including acute myeloid leukemia... 
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.